These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 10463079)
1. An antisense oligonucleotide primer. Hogrefe RI Antisense Nucleic Acid Drug Dev; 1999 Aug; 9(4):351-7. PubMed ID: 10463079 [No Abstract] [Full Text] [Related]
2. Therapeutic applications of antisense oligonucleotides in asthma and allergy. Isidoro-García M; Dávila I Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):171-5. PubMed ID: 19075979 [TBL] [Abstract][Full Text] [Related]
3. Potential for transcatheter application of antisense oligonucleotides for the treatment of vascular diseases. Morishita R; Gibbons GH; Dzau VJ J Interv Cardiol; 1995 Aug; 8(4):377-81. PubMed ID: 10155251 [No Abstract] [Full Text] [Related]
4. The macrophage as a Trojan horse for antisense oligonucleotide delivery. Novak JS; Jaiswal JK; Partridge TA Expert Opin Ther Targets; 2018 Jun; 22(6):463-466. PubMed ID: 29860876 [No Abstract] [Full Text] [Related]
14. Less is more: therapeutic exon skipping for Duchenne muscular dystrophy. Aartsma-Rus A; van Ommen GJ Lancet Neurol; 2009 Oct; 8(10):873-5. PubMed ID: 19713153 [No Abstract] [Full Text] [Related]
15. Antisense technologies have a future fighting neurodegenerative diseases. Seidman S; Eckstein F; Grifman M; Soreq H Antisense Nucleic Acid Drug Dev; 1999 Aug; 9(4):333-40. PubMed ID: 10463077 [TBL] [Abstract][Full Text] [Related]
16. Influence of diverse chemical modifications on the ADME characteristics and toxicology of antisense oligonucleotides. Dirin M; Winkler J Expert Opin Biol Ther; 2013 Jun; 13(6):875-88. PubMed ID: 23451977 [TBL] [Abstract][Full Text] [Related]
17. Delivery of anti-microRNA-21 antisense-oligodeoxynucleotide using amphiphilic peptides for glioblastoma gene therapy. Song H; Oh B; Choi M; Oh J; Lee M J Drug Target; 2015 May; 23(4):360-70. PubMed ID: 25572456 [TBL] [Abstract][Full Text] [Related]
18. Antisense oligonucleotide technology: from EST to therapeutics. Giles RV Curr Opin Mol Ther; 2000 Jun; 2(3):238-52. PubMed ID: 11249617 [TBL] [Abstract][Full Text] [Related]
19. Progress in antisense research and development. Thierry AR; Bradley MO; Chrisey LA Antisense Res Dev; 1993; 3(4):411-6. PubMed ID: 8155983 [No Abstract] [Full Text] [Related]